Published in Arch Intern Med on June 01, 1975
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest (1985) 3.85
Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ (1995) 3.37
Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes? Endocr Rev (2009) 2.65
Association between serum uric acid and development of type 2 diabetes. Diabetes Care (2009) 2.49
Education, income, occupation, and the 34-year incidence (1965-99) of Type 2 diabetes in the Alameda County Study. Int J Epidemiol (2005) 2.37
Cigarette smoking and the risk of diabetes in women. Am J Public Health (1993) 1.95
A prospective study of whole-grain intake and risk of type 2 diabetes mellitus in US women. Am J Public Health (2000) 1.68
Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ (2006) 1.65
Smoking and diabetes in Chinese men. Postgrad Med J (2001) 1.55
Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol (2008) 1.54
Determinants of plasma glucose level and diabetic status in a northern Canadian Indian population. CMAJ (1990) 1.11
Excess body mass index-years, a measure of degree and duration of excess weight, and risk for incident diabetes. Arch Pediatr Adolesc Med (2012) 1.06
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. Ann Epidemiol (2007) 1.06
Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiol Community Health (1996) 0.98
Short-term weight change and fluctuation as risk factors for type 2 diabetes in Finnish male smokers. Eur J Epidemiol (2010) 0.94
Racial and ethnic differences in cardio-metabolic risk in individuals with undiagnosed diabetes: National Health and Nutrition Examination Survey 1999-2008. J Gen Intern Med (2012) 0.94
Comparison of the serum iron, ferritin levels and total iron-binding capacity between pregnant women with and without gestational diabetes. J Nat Sci Biol Med (2013) 0.85
Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis. Cardiovasc Diabetol (2007) 0.84
Thyroid disease in diabetics. Postgrad Med J (1982) 0.81
The development of a mobile u-Health program and evaluation for self-diet management for diabetic patients. Nutr Res Pract (2016) 0.75
Epidemiologic evidence for cardiovascular disease initiatives in Israel and the United States. Public Health Rep (1984) 0.75
Fasting serum insulin levels and insulin resistance are associated with blood rheology in Japanese young adults without diabetes. J Int Med Res (2016) 0.75
Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study. PLoS One (2017) 0.75
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Illuminating the 'black box'. A description of 4454 patient visits to 138 family physicians. J Fam Pract (1998) 4.70
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA (1998) 3.37
In-hospital and 1-year mortality in 1,524 women after myocardial infarction. Comparison with 4,315 men. Circulation (1991) 2.13
Long-term mortality follow-up of hospital survivors of a myocardial infarction randomized to nifedipine in the SPRINT study. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Cardiovasc Drugs Ther (1998) 2.01
Self-reported physical activity predicts long-term coronary heart disease and all-cause mortalities. Twenty-one-year follow-up of the Israeli Ischemic Heart Disease Study. Arch Fam Med (1995) 1.96
Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males inIsrael. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol (1977) 1.78
Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men. Arterioscler Thromb Vasc Biol (1997) 1.76
High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study. Am J Epidemiol (1979) 1.75
Diabetes mellitus in midlife and the risk of dementia three decades later. Neurology (2004) 1.70
Long-term prognosis of women after myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am J Epidemiol (1997) 1.62
Factors predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli Ischemic Heart Disease Study. Cardiology (1993) 1.60
Does diuretic therapy increase the risk of renal cell carcinoma? Am J Cardiol (1999) 1.60
The periodic health examination of older adults: the recommendations of the U.S. Preventive Services Task Force. Part II. Screening tests. J Am Geriatr Soc (1990) 1.58
Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med (1976) 1.58
Voluntary and involuntary weight loss: associations with long term mortality in 9,228 middle-aged and elderly men. Am J Epidemiol (1998) 1.56
Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up. Cardiology (1999) 1.52
Total and high density lipoprotein cholesterol in the serum and risk of mortality: evidence of a threshold effect. Br Med J (Clin Res Ed) (1985) 1.44
Mortality trends in men and women with acute myocardial infarction in coronary care units in Israel. A comparison between 1981-1983 and 1992-1994. For the SPRINT and the Israeli Thrombolytic Survey Groups. Eur Heart J (2000) 1.43
Health and function in the old and very old. J Am Geriatr Soc (1988) 1.43
Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors: a cohort study of 11,575 patients with coronary artery disease. J Am Coll Cardiol (1999) 1.42
The periodic health examination of older adults: the recommendations of the U.S. Preventive Services Task Force. Part I. Counseling, immunizations, and chemoprophylaxis. J Am Geriatr Soc (1990) 1.41
Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1996) 1.41
Primary ventricular tachycardia in acute myocardial infarction: clinical characteristics and mortality. The SPRINT Study Group. Ann Intern Med (1992) 1.41
Calcium antagonists and mortality in patients with coronary artery disease: a cohort study of 11,575 patients. J Am Coll Cardiol (1996) 1.40
Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group. J Am Coll Cardiol (1998) 1.40
Behavioral inhibition in children of parents with panic disorder and agoraphobia. A controlled study. Arch Gen Psychiatry (1988) 1.32
An epidemiologic investigation of hypertension and ischemic heart disease within a defined segment of the adult male population of Israel. Isr J Med Sci (1968) 1.30
Diabetes, prediabetes and uricaemia. Diabetologia (1976) 1.29
Factors related to diabetes incidence: a multivariate analysis of two years observation on 10,000 men. The Israel Ischemic Heart Disease Study. J Chronic Dis (1971) 1.28
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies. Stat Med (2009) 1.27
Uric acid and diabetes: observations in a population study. Lancet (1982) 1.24
Five-year myocardial infarction incidence. II. Association of single variables to age and birthplace. J Chronic Dis (1973) 1.22
Blood groups, myocardial infarction and angina pectoris among 10,000 adult males. N Engl J Med (1971) 1.22
The family life cycle and its implications for family practice. J Fam Pract (1979) 1.21
Family determinants of disease. I. General principles and concepts. Fam Pract (1984) 1.18
Patient perceptions of humanism in physicians: effects on positive health behaviors. Fam Med (1991) 1.16
Genetic aspects of arteriosclerosis. Arteriosclerosis (1986) 1.16
Comprehensive follow-up of carcinoma patients. J Chronic Dis (1971) 1.15
Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors. Ann Intern Med (1976) 1.13
Elevated serum triglyceride levels and long-term mortality in patients with coronary heart disease: the Bezafibrate Infarction Prevention (BIP) Registry. Circulation (1999) 1.13
The epidemiology of coronary heart disease in the ethnically and culturally diverse population of Israel. A review. Isr J Med Sci (1982) 1.13
High-density lipoprotein cholesterol and risk of ischemic stroke mortality. A 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study. Stroke (1997) 1.12
Weight-height indices. Choice of the most suitable index and its association with selected variables among 10,000 adult males of heterogeneous origin. Br J Prev Soc Med (1974) 1.12
Long-term prognosis of patients with paroxysmal atrial fibrillation complicating acute myocardial infarction. SPRINT Study Group. Eur Heart J (1992) 1.11
Diabetes mellitus among 10,000 adult men. I. Five-year incidence and associated variables. Isr J Med Sci (1974) 1.11
The predictive value of admission heart rate on mortality in patients with acute myocardial infarction. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. J Clin Epidemiol (1995) 1.08
The incidence of hypertension and associated factors: the Israel ischemic heart disease study. Am Heart J (1972) 1.06
Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation (2001) 1.05
Random repeat 24-hour dietary recalls. Am J Clin Nutr (1971) 1.04
Circadian variation and possible external triggers of onset of myocardial infarction. SPRINT Study Group. Am J Med (1993) 1.04
Antihypertensive therapy and the risk of malignancies. Eur Heart J (2001) 1.04
Malignant arrhythmias in relation to values of serum potassium in patients with acute myocardial infarction. Int J Cardiol (1991) 1.04
Characteristics of smokers, nonsmokers and ex-smokers among 10,000 adult males in Israel. I. Distribution of selected sociodemographic and behavioral variables and the prevalence of disease. Isr J Med Sci (1975) 1.03
Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial. Am Heart J (1997) 1.03
Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med (1992) 1.02
Congenital dislocation of the hip--a clinical-epidemiological study, Jerusalem 1954 to 1960. I. Retrospective incidence study. Isr J Med Sci (1966) 1.01
The frequency of sexual problems among family practice patients. Fam Pract Res J (1988) 1.01
Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol (1983) 0.99
Myocardial infarction over a five-year period. I. Prevalence, incidence and mortality experience. J Chronic Dis (1973) 0.99
Cardiogenic shock complicating acute myocardial infarction in patients without heart failure on admission: incidence, risk factors, and outcome. SPRINT Study Group. Am J Med (1993) 0.99
Serum uric acid: correlation with biochemical, anthropometric, clinical and behavioral parameters in 10,000 Israeli men. J Chronic Dis (1980) 0.98
Arterial enlargement in the atherosclerosis risk in communities (ARIC) cohort. In vivo quantification of carotid arterial enlargement. The ARIC Investigators. Stroke (1994) 0.98
Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group. Am J Cardiol (1996) 0.97
Complete atrioventricular block complicating inferior acute wall myocardial infarction: short- and long-term prognosis. Am Heart J (1993) 0.97
Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics. Diabetologia (1977) 0.97
Enhanced risk of coronary heart disease mortality in lean hypertensive men. Hypertension (1987) 0.97
Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) Study Group. Arterioscler Thromb Vasc Biol (1996) 0.96
Are lean smokers at increased risk of lung cancer? The Israel Civil Servant Cancer Study. Arch Intern Med (1996) 0.95
Adult-onset diabetes among Arabs and Jews in Israel: a population-based study. Diabet Med (2012) 0.94
Clinical myocardial infarction over a five-year period--III. A multivariate analysis of incidence, the Israel ischemic heart disease study. J Chronic Dis (1975) 0.94
Birth defects monitoring. Am J Ind Med (1983) 0.94
High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal? Arch Intern Med (2000) 0.94